11/26/2024 2:22:35 PM IPOs in Life Sciences By James Baillieu Fiona McFarlane The amount of capital required to develop and bring a drug to market is significant. It is estimated that it costs US$1-2 billion to...
11/13/2024 1:39:46 PM M&A in Life Sciences By James Baillieu Companies in the life sciences sector and its sub-sectors, including pharmaceuticals, medical devices, diagnostics and services, are...
11/4/2024 10:13:36 AM Licensing and Collaborations in Life Sciences By James Baillieu Sally Shorthose There is a huge cost of bringing a pharmaceutical product to market, with estimates ranging from US$1-2 billion to take a product from...
10/18/2024 10:26:12 AM Venture Capital and Venture Debt in Life Sciences By James Baillieu In recent decades, venture capital (VC) has played an increasingly important role in the high-risk and high-reward life sciences sector....
9/17/2024 11:38:01 AM The DNA of Life Sciences Deals By James Baillieu Maria John The life sciences sector, comprising of sub-sectors like pharmaceuticals, medical devices, diagnostics and services, aims to cure disease...